Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tumors in the elderly].

H Rübben1, G Lümmen

  • 1Klinik und Poliklinik für Urologie, Universitätsklinik Essen, Hufelandstrasse 55, 45122 Essen. herbert.ruebben@uni-essen.de

Der Urologe. Ausg. A
|September 7, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers].

Der Urologe. Ausg. A·2020
Same author

Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

World journal of urology·2020
Same author

[Urinary bladder cancer as a late sequela of spinal cord injury : Decision-making aids for assessment of this causal association].

Der Urologe. Ausg. A·2020
Same author

[Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases].

Der Urologe. Ausg. A·2018
Same author

[Incontinence].

Der Urologe. Ausg. A·2017
Same author

[When is surgical treatment indicated in metastatic urothelial carcinoma and what is the scientific rationale?]

Der Urologe. Ausg. A·2017
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Cancer treatment in elderly patients is complex due to age-related physiological changes and limited clinical trial data. While some surgeries show promise, chemotherapy poses higher toxicity risks for older adults.

Area of Science:

  • Geriatric Oncology
  • Cancer Epidemiology
  • Clinical Therapeutics

Context:

  • Cancer prevalence and incidence increase with age, leading to a growing population of elderly cancer patients.
  • Physiological changes in the elderly, such as declining renal function and altered drug metabolism, impact treatment tolerance.
  • Elderly individuals are often underrepresented in clinical trials, limiting evidence-based treatment guidelines.

Purpose:

  • To review the current understanding of cancer treatment in elderly patients.
  • To highlight the challenges and considerations for managing cancer in older adults.
  • To address the disparities in clinical trial participation and data availability for this demographic.

Summary:

  • Surgical procedures like radical cystectomy and prostatectomy can be safely performed in selected elderly patients (70+ years) with comparable outcomes to younger individuals.

Related Experiment Videos

  • Chemotherapy presents increased toxicity risks in the elderly due to age-related physiological declines.
  • A persistent belief exists that the elderly benefit less from and experience greater toxicity with chemotherapy compared to younger patients, largely due to data limitations.

    • Impact:

    • Emphasizes the need for careful patient selection and tailored treatment approaches for elderly cancer patients.
    • Underscores the critical gap in clinical trial data for older adults, necessitating further research.
    • Promotes a more nuanced understanding of cancer treatment efficacy and safety in the geriatric population.